Stockreport

Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ... [Yahoo! Finance]

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF Grant Revenue: $4.4 million year-to-date 2024, compared to $3.6 million in the same period of 2023. Total Operating Loss: $10.8 million year-to-date 2024, compared to [Read more]